Who
The study involved 87 drug-resistant tuberculosis (DR-TB) patients aged 18 years or older who were receiving treatment and attending routine monthly follow-up visits at Universitas Indonesia Hospital. Most participants were male and aged 18–59 years.
What
The study assessed medication adherence levels among DR-TB patients. Results showed that 50.6% of patients had low adherence, 47.1% moderate adherence, and only 2.3% high adherence. Adherence was significantly associated with gender, and tended to be higher among females, patients aged 18–59 years, those with secondary education, new TB cases, and patients receiving long-term treatment regimens.
When
The study was conducted between February and March 2024.
Where
The research took place at Universitas Indonesia Hospital in Depok City, Indonesia.
Why
The study aimed to evaluate treatment adherence among DR-TB patients, as poor adherence can compromise treatment effectiveness, prolong therapy, and increase the risk of poor clinical outcomes in DR-TB management.
How
An observational cross-sectional study design was used. Data were collected using the validated Indonesian version of the Morisky Medication Adherence Scale (MMAS-8). Adherence scores were classified into low (<6), moderate (6 to <8), and high (8). Associations between patient characteristics and adherence levels were analyzed.
Source: Harahap, D.W.S., Andrajati, R., Sari, S.P. and Handayani, D., 2024. Medication Adherence among Drug-Resistant Tuberculosis (DR-TB) Patients at Universitas Indonesia Hospital. Jurnal Respirologi Indonesia, 44(3), pp.196-200.
No comments:
Post a Comment